Authors: Rains, Jeanetta C; Penzien, Donald B

Source: Expert Review of Neurotherapeutics, Volume 2, Number 5, September 2002 , pp. 749-760(12)

Publisher: Expert Reviews

Abstract:

Behavioral treatments have become widely accepted interventions for migraine and tension-type headache. Ample empirical evidence supports the effectiveness of interventions, such as relaxation training, biofeedback and cognitive–behavioral (i.e., stress-management) treatments. Such interventions may be utilized alone or in combination with the more widely used pharmacological treatments for headache. Behavioral approaches are often the treatments of choice for patients who have contraindications to or who are refractory to traditional pharmacologic interventions. Recent research has attempted to increase the availability of behavioral treatments to patients through more cost-effective forms of treatment administration. Ample empirical evidence now indicates that these efficient interventions are just as effective as more time-intensive, individually administered clinic-based treatments. Important future directions for behavioral headache treatments include: integration into the primary care setting, developing algorithms for matching behavioral and pharmacologic treatments to patient characteristics for maximum effectiveness, behavioral skills training to enhance outcomes with pharmacologic interventions and reduce complications (e.g., rebound migraine), as well as identifying and treating comorbid conditions that undermine treatment.

Keywords: behavioral; biofeedback; headache; meta-analysis; migraine; psychological; relaxation; stress management; treatment; treatment guideline

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737175.2.5.749

Publication date: 2002-09-01

More about this publication?

• Expert Review of Neurotherapeutics provides expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology ,  Neuropsychology
• By this author: Rains, Jeanetta C ;  Penzien, Donald B

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers